Multiple potential mechanisms through which COVID-19 could induce changes in nociceptor excitability have been hypothesized [8], further supported by an altered expression of neurotrophins in serum and saliva from COVID-19 patients [9,10]. This evidence concerns the gene BDNF and COVID-19.